Back to search
FDAFDA · Food and drugs·Recall number D-0267-2023

Thiamine Hydrochloride 3000 mg/30 mL (100mg/mL), Riboflavin 30 mg/30 mL (1mg/mL) Injection, FOR INTRAMUSCULAR OR SLOW INTRAVENOUS USE, 30 mL Sterile Multiple Use Vial, Rx Only, Compounded for a licensed professional or patient use by: McGuff Compounding Pharmacy Services, Inc, Santa Ana, CA 92704.

Published February 22, 2023 · Recall initiated: December 8, 2022

Summary

FDA records drug Class II recall D-0267-2023, published February 22, 2023 and initiated December 8, 2022. Recalling firm: McGuff Compounding Pharmacy Services, Inc.; Status: Terminated; Reported quantity: 255 vials; Lot: Lot: 22K1661, initial BUD: 12/18/2022, extended BUD: 1/27/2023; 22J2401, BUD: 12/19/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
McGuff Compounding Pharmacy Services, Inc.
Distributor
Nationwide in the USA
Lot
Lot: 22K1661, initial BUD: 12/18/2022, extended BUD: 1/27/2023; 22J2401, BUD: 12/19/2022.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Thiamine Hydrochloride 3000 mg/30 mL (100mg/mL), Riboflavin 30 mg/30 mL (1mg/mL) Injection, FOR INTRAMUSCULAR OR SLOW INTRAVENOUS USE, 30 mL Sterile Multiple Use Vial, Rx Only, Compounded for a licensed professional or patient use by: McGuff Compounding Pharmacy Services, Inc, Santa Ana, CA 92704. recalled?

Yes. FDA published recall D-0267-2023 on February 22, 2023. Reported hazard: Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.

What should I do if I have this product?

Voluntary: Firm initiated · Letter